Azilsartan medoxomil is an active pharmaceutical ingredient (API) and angiotensin II receptor blocker (ARB) used in the formulation of medications for the treatment of hypertension (high blood pressure). As a prodrug, it is hydrolyzed in the body to its active form, azilsartan, which selectively antagonizes the AT1 receptor, blocking the vasoconstrictive and sodium-retaining effects of angiotensin II. This action relaxes blood vessels, reduces blood volume, and lowers blood pressure. It is supplied as a white to off-white solid with high purity (≥97.5%) for pharmaceutical manufacturing, research, and development purposes. Note: This is the chemical compound, not a finished dosage form; consult healthcare professionals for therapeutic use.